Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus

290 adults (18-75 years) with type 2 diabetes mellitus. Exclusions: atrial flutter or fibrillation, pacemaker, history of severe liver or kidney disease (eGFR <30 ml/min/1.73 m2), heart failure stage III and IV, acute illness or hypoglycemia in the previous 24 h, and use of antiarrhythmic drugs (other than beta-blockers), antidepressants, or antihistamines.

Association between abnormal pulse wave velocity (PWV >90th percentile for age) and cardiac autonomic nervous system activity (measured by heart rate variability parameters)surrogate